Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody

Loading news article.

Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody | WAPE

Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody

Article summary

Related companies

Comments —